Description
Speakers:
Dr. Séverine Crettol Wavre PharmD, PhD
- Clinical senior lecturer, Clinical Pharmacologist (Swiss Society of Clinical Pharmacology and Toxicology). Joint deputy head of the unit, Unit of Pharmacogenetics and Clinical Psychopharmacology, Psychiatry Department, University of Lausanne, Switzerland
Dr Juliette Lagreula, PharmD, PhD
- Clinical pharmacist. Pharmacogenetics and Clinical Psychopharmacology Unit, Psychiatry Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Learning objectives
After the webinar, participants should be able to:
- Understand the concept of genetic polymorphism and pharmacogenetics
- Understand the impact of pharmacogenetics of CYP450 isoforms (e.g. CYP2D6) on plasma concentration of drugs
- Understand the impact of pharmacogenetics on drug toxicity
- Understand the impact of pharmacogenetics on frequently prescribed psychotropics
Description
This webinar will help the participants understand the impact of pharmacogenetics on drug response and adverse events.
Séverine Crettol Wavre : Pharmacist with a PhD on the pharmacogenetics of methadone, I serve as the Joint Deputy Head of the Unit of Pharmacogenetics and Clinical Psychopharmacology within the Psychiatry Department of the University Hospital of Lausanne, Switzerland. In our laboratory, we are specialized in the therapeutic drug monitoring (TDM) of psychotropic drugs, as well as pharmacogenetic testing including genotyping and phenotyping test of CYP450 enzymes. The clinical interpretation of all our analyses is our strength. This precision medicine approach helps to tailor psychotropic treatments to each patient’s unique profile, to improve outcomes and reduce adverse effects. Our unit has also developed a psychopharmacology telephone consultation for healthcare professionals (from the hospital or private practice) and we take part in clinical case discussion seminars with the different inpatient and outpatient units of the Department of Psychiatry.
Juliette Lagreula, PharmD, PhD: Hospital and clinical pharmacist with a PhD in psychiatric pharmacotherapy from UCLouvain, Belgium, and experiences in the UK (University of Bath) and Canada (Université de Montréal), I currently work at the Pharmacogenetics and Clinical Psychopharmacology Unit, Psychiatry Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
